ReviewOncoTargets and therapy2017

Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer: patient selection and special considerations.

Sheel A Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.